Submit Deal

VENROCK HEALTHCARE CAPITAL PARTNERS

HQ - London

Summary

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies

Deals Overview

Total Deals12

Valued Deals10

Total Value£ 1.55 B

Avg. Deal Size£ 155 M

Market Context

Senior Management

Brian Ascher
Partner
Alex Rosen
Managing Director and Partner
Andrew Gottesdiener
Partner

Sort

aadi bioscience inc

HQ - United States

Pharmaceuticals

26 Aug 2021

Investment Date

100%

Stake

n/a

Deal Value

lusaris therapeutics

HQ - United States

Biotechnology

2 Nov 2022

Investment Date

£ 52 M

Deal Value

apogee therapeutics

HQ - United States

Biotechnology

7 Dec 2022

Investment Date

£ 122 M

Deal Value

upstream bio

HQ - United States

Biotechnology

8 Jun 2023

Investment Date

£ 160 M

Deal Value

carmot therapeutics

HQ - United States

Biotechnology

25 May 2023

Investment Date

£ 120 M

Deal Value

mirador therapeutics

HQ - United States

Pharmaceuticals

21 Mar 2024

Investment Date

£ 314 M

Deal Value

lycia therapeutics

HQ - United States

Biotechnology

13 May 2024

Investment Date

£ 85 M

Deal Value

aerovate therapeutics

HQ - United States

Biotechnology

28 Apr 2025

Investment Date

100%

Stake

n/a

Deal Value

adcendo aps

HQ - Denmark

Biotechnology

25 Nov 2024

Investment Date

£ 107 M

Deal Value

timberlyne therapeutics

HQ - United States

Biotechnology

9 Jan 2025

Investment Date

£ 145 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy